Other methylated targets found in plasma from BrCa patients with a diagnostic value encompass SOX17, CST6, APC, DAK-K, MASPIN, HIC-1, HIN-1, RARB, RARbeta2, GSTP1, BRCA1, and KIF1A [32,129,130,131,132,136,137,138,139]. The gene discussed is SOX17; the disease is invasive breast carcinoma.